Ausper Biopharma Co., Ltd.

This study is testing an investigational drug called AHB-137 in adults with a specific type of chronic hepatitis B. Participants are already taking stable antiviral pills. The goal is to see if adding AHB-137 can further reduce the amount of virus in the blood and potentially imp…

This study is testing whether a new injection called AHB-137, when given alongside other hepatitis B treatments, can help patients with a certain type of chronic hepatitis B safely stop their long-term antiviral pills. Researchers will enroll 127 adults who are already taking ant…

This early-stage study is testing a new injectable drug called AHB-137 for people with chronic Hepatitis B. The main goals are to check if the drug is safe and to see if it can reduce the amount of virus in the body. The study includes both healthy volunteers and Hepatitis B pati…

This large, late-stage study is testing whether a new injection called AHB-137 can help people with a specific type of chronic hepatitis B. The goal is to see if the injection can keep the virus under control even after participants stop taking their current daily antiviral pills…

This study is testing an experimental drug called AHB-137 in adults with chronic hepatitis B who have never received treatment. The main goal is to see if the drug can reduce the hepatitis B virus to very low or undetectable levels in the blood. Researchers will also monitor side…